Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics

Br J Cancer. 2014 May 13;110(10):2615-22. doi: 10.1038/bjc.2014.176. Epub 2014 Apr 1.

Abstract

Background: The revolution in cancer genomics shows that the dominant mutations are CG->TA transitions. The sources of these mutations are probably two host cell cytidine deaminases APOBEC3A and APOBEC3B. The former in particular can access nuclear DNA and monotonously introduce phenomenal numbers of C->T mutations in the signature 5'TpC context. These can be copied as G->A transitions in the 5'GpA context.

Methods: DNA hypermutated by an APOBEC3 enzyme can be recovered by a technique called 3DPCR, which stands for differential DNA denaturation PCR. This method exploits the fact that APOBEC3-edited DNA is richer in A+T compared with the reference. We explore explicitly 3DPCR error using cloned DNA.

Results: Here we show that the technique has a higher error rate compared with standard PCR and can generate DNA strands containing both C->T and G->A mutations in a 5'GpCpR context. Sequences with similar traits have been recovered from human tumour DNA using 3DPCR.

Conclusions: Differential DNA denaturation PCR cannot be used to identify fixed C->T transitions in cancer genomes. Presently, the overall mutation frequency is ∼10(4)-10(5) base substitutions per cancer genome, or 0.003-0.03 kb(-1). By contrast, the 3DPCR error rate is of the order of 4-20 kb(-1) owing to constant selection for AT DNA and PCR-mediated recombination. Accordingly, sequences recovered by 3DPCR harbouring mixed C->T and G->A mutations associated with the 5'GpC represent artefacts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APOBEC Deaminases
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / metabolism
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism
  • Cells, Cultured
  • Cytidine / metabolism
  • Cytidine Deaminase
  • Cytosine Deaminase / metabolism*
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / metabolism*
  • Hepatitis B, Chronic / complications
  • Hepatitis C, Chronic / complications
  • Humans
  • Interferon-alpha / pharmacology
  • Interleukin-2 / pharmacology
  • Liver Neoplasms / etiology
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism
  • Mutation*
  • Neoplasm Proteins / metabolism*
  • Nucleic Acid Denaturation
  • Phytohemagglutinins / pharmacology
  • Polymerase Chain Reaction / methods*
  • Recombination, Genetic
  • Temperature
  • beta Catenin / genetics

Substances

  • CTNNB1 protein, human
  • DNA, Neoplasm
  • Interferon-alpha
  • Interleukin-2
  • Neoplasm Proteins
  • Phytohemagglutinins
  • beta Catenin
  • Cytidine
  • Cytosine Deaminase
  • APOBEC Deaminases
  • APOBEC3 proteins, human
  • Cytidine Deaminase